Live from the NIH registry
Studies recruiting near Galveston right now
Top 25 of 203 recruiting studies, sorted by proximity — each links to its official registry page
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: SWOG Cancer Research Network
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Texas Oncology - Gulf Coast ( Site 8009) — Webster, Texas (24.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
MD Anderson Cancer center — League City, Texas (21.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Diabetes Mellitus, Hypertension
N/A
Interventional 1,022 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
The University of Texas Medical Branch UTMB — Galveston, Texas (6.7 mi)
· Sponsor: Calliditas Therapeutics AB
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 714 participants sought
The University of Texas, MD Anderson Cancer Center - League City — League City, Texas (21.7 mi)
· Sponsor: Pfizer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
UT MD Anderson - League City — League City, Texas (21.7 mi)
· Sponsor: NRG Oncology
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Maximos Ob/Gyn — League City, Texas (21.7 mi)
· Sponsor: Pfizer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Center for Clinical Studies — Webster, Texas (24.2 mi)
· Sponsor: Eli Lilly and Company
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjögren, Sjogren Disease
Phase 1
Interventional 36 participants sought
Cullinan Investigative Site — Webster, Texas (24.2 mi)
· Sponsor: Cullinan Therapeutics Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 3
Interventional 486 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: NRG Oncology
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Earle Research /ID# 248501 — Friendswood, Texas (26.9 mi)
· Sponsor: AbbVie
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Advanced/Metastatic Solid Tumors, Bladder Cancer
Phase 1
Interventional 310 participants sought
The University of Texas, MD Anderson Cancer Center - League City — League City, Texas (21.7 mi)
· Sponsor: Pfizer
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Emotional Distress, Prosocial Behavior
N/A
Interventional 800 participants sought
Communities in Schools of Galveston County — La Marque, Texas (9.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Non-small Cell Lung Cancer, Colorectal Carcinoma
Phase 1
Interventional 108 participants sought
Research Site — Galveston, Texas (6.7 mi)
· Sponsor: AstraZeneca
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Houston Methodist Saint John Hospital — Nassau Bay, Texas (23.7 mi)
· Sponsor: NRG Oncology
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Gulf Coast — Webster, Texas (24.2 mi)
· Sponsor: Pfizer
Primary Subtalar Arthrodesis for Calcaneal Fractures
Calcaneus Fracture
N/A
Interventional 218 participants sought
The University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Wake Forest University Health Sciences
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 114 participants sought
Center for Clinical Studies — Webster, Texas (24.2 mi)
· Sponsor: Oneness Biotech Co., Ltd.
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Moderate to Severe Glabellar Lines
Phase 3
Interventional 1,300 participants sought
Center for Clinical Studies — Webster, Texas (24.2 mi)
· Sponsor: Ipsen
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: Biostar Pharma, Inc.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: BriaCell Therapeutics Corporation
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Post Operative Pulmonary Complications, Neuromuscular Blockade
Phase 4
Interventional 490 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston